According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 2,04ย โฌ. In 2022 the company made an earnings per share (EPS) of 1,82ย โฌ an increase over its 2021 EPS that were of 1,26ย โฌ.